@Hansmann_Lab
Joined May 2017
  • Tweets54
  • Following48
  • Followers55
29Media
A new basic-translational research paper from our Land Michael Bader's group has been published: Legchenko et al. Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, ... (2024). JACC Basic Transl Science. jacc.org/doi/10.1016/j.jacbt… @3CPRCouncil @ATS_PC @PVRI @StanfordCVI
1
44
NEW PAPER published: Hysko K et al. JACC Advances (2023) - open access. Recovery of Biventricular Function After Catheter Intervention or Surgery for Neonatal Coarctation of the Aorta. jacc.org/doi/abs/10.1016/j.j… @3CPRCouncil @AEPCcongenital @StanfordCVI @BostonChildrens
121
Breakthrough stem cell treatment for pulmonary hypertension trialed newsweek.com/doctors-treat-s…

Breakthrough Stem Cell Treatment for Pulmonary Hypertension Trialed

Researchers have said that the treatment, using umbilical cord stem cell products, was the first of its kind in preventing the fatal course of the disease.

newsweek.com
1
1
4
Georg Hansmann Lab retweeted
Georg Hansmann Lab@Hansmann_Lab14 Jun 2022
Signale fürs Leben zeitung.faz.net/faz/natur-un… # via @faznet
1
Research|@Hansmann_Lab et al. show that serial intravascular infusions of conditioned media from human umbilical cord #MesenchymalStemCells improved clinical features of a child with #pulmonaryarterialhypertension #PAH. @MartinGiera,@RalserLab,@PVD_Network nature.com/articles/s44161-0…
6
1
11
Signale fürs Leben zeitung.faz.net/faz/natur-un… # via @faznet
1
Georg Hansmann Lab retweeted
Georg Hansmann Lab@Hansmann_Lab10 Jun 2022
New paper from @Hansmann_Lab : HUCMSC/HUCMSC-CM has the potential to become a real game changer in the treatment of severe PAH and RV failure, by driving regeneration, mitochondrial function, autophagy and anti-inflammation. nature.com/articles/s44161-0…
1
5
2
5
Georg Hansmann Lab retweeted
Georg Hansmann Lab@Hansmann_Lab10 Jun 2022
NEW PAPER from @Hansmann_Lab, in collaboration with @RalserLab, @MartinGiera, Ralf Hass rdcu.be/cPjSm HUCMSC/HUCMSC-CM has the potential to become a real game changer in PAH therapy @3CPRCouncil @ATS_PC @PVRI @PHAssociation @StanfordCVI @BostonChildrens @AEPCcongenital
4
13
Georg Hansmann Lab retweeted
PVD Network@PVD_Network13 Jun 2022
The Right Heart phassociation.org/the-right-…

Right Heart Blog

PHA’s Right Heart Blog shows the Pulmonary Hypertension Association community’s sense of adventure, altruism and determination.

phassociation.org
2
Georg Hansmann Lab retweeted
PVD Network@PVD_Network12 Jun 2022
Faculty Dinner part #2, 2nd EPPVDN PH/HF Symposium, June 11, 2022 at Prater Biergarten Berlin. Great people meeting after a full day of phantastic science. 2 more sessions to come. @3CPRCouncil @ATS_PC @PVRI @PHAssociation @StanfordCVI @BostonChildrens @AEPCcongenital @PittVMI
4
2
8
Georg Hansmann Lab retweeted
PVD Network@PVD_Network12 Jun 2022
Faculty Dinner part #1, 2nd EPPVDN PH/HF Symposium, June 11, 2022, at Prater Biergarten, Berlin. Great group of people meeting after a full day of phantastic science. gh @3CPRCouncil @ATS_PC @PVRI @PHAssociation @StanfordCVI @BostonChildrens @AEPCcongenital @PittVMI
2
1
11
New paper from @Hansmann_Lab : HUCMSC/HUCMSC-CM has the potential to become a real game changer in the treatment of severe PAH and RV failure, by driving regeneration, mitochondrial function, autophagy and anti-inflammation. nature.com/articles/s44161-0…
1
5
2
5
NEW PAPER from @Hansmann_Lab, in collaboration with @RalserLab, @MartinGiera, Ralf Hass rdcu.be/cPjSm HUCMSC/HUCMSC-CM has the potential to become a real game changer in PAH therapy @3CPRCouncil @ATS_PC @PVRI @PHAssociation @StanfordCVI @BostonChildrens @AEPCcongenital
4
13
2nd PH/Heart Failure Symposium in June (11-12th) in Berlin. 3 basic, 3 clinical sessions. Awesome speakers. Register now! Clinical workshop on preceeding Friday (June 10). pvdnetwork.org/2nd-internati… #WorldPHDay @3CPRCouncil @ATS_PC @PVRI @PHAssociation @PittVMI @PhatStanford
NEW PAPER OUT:Hamberger F et al. Frontiers Cardiovasc Med, 2022. frontiersin.org/articles/10.… Fibrogenic signature in patients with hepatic congestion due to heart disease: PAH patients should be screened for unrecognized liver fibrosis. #WorldPHDay,#hepatology, @3CPRCouncil, @ATS_PC
NEW PAPER OUT, 02/2022: Hansmann G et al. Even in end-stage pediatric PAH with poor RV function and low cardiac output, LuTx should be preferred over Heart-LuTx. @3CPRCouncil, @ATS_PC, @PVRI, @PHAssociation, @PittVMI, @PhatStanford jhltonline.org/article/S1053… thejhlt.libsyn.com/jhlt-the-…
NEW PAPER OUT: Iablonskii P et al. JHLT, issue 2/2022 Indications and outcome after lung transplantation in children under 12 years of age: A 16-year single center experience. jhltonline.org/article/S1053… @3CPRCouncil @ATS_PC @PVRI @PHAssociation @PittVMI @PhatStanford
NEW PAPER OUT: Diekmann et al. Front Cardiovasc Med. 2021 Circulating Interleukin-7 in Human Pulmonary Arterial Hypertension. frontiersin.org/articles/10.… @3CPRCouncil @ATS_PC @PVRI @PHAssociation @PittVMI @PhatStanford
1
NEW PAPER OUT: Chouvarine et al., STAR Protocols, 2021. Construction of transcriptional regulatory networks using total RNA-seq data. (methods paper) @3CPRCouncil @ATS_PC @PVRI @PHAssociation @PittVMI @PHatStanford sciencedirect.com/science/ar…
3
5
NEW PAPER OUT: Diekmann et al., Int J Mol Sci, 2021. Soluble Receptor for Advanced Glycation End Products (sRAGE) is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension. @3CPRCouncil @ATS_PC @PVRI @PHAssociation @PittVMI @PHatStanford mdpi.com/1422-0067/22/16/859…
3
5
Load more